MX2020000182A - Cepa bacillus subtilis con actividad probiotica. - Google Patents

Cepa bacillus subtilis con actividad probiotica.

Info

Publication number
MX2020000182A
MX2020000182A MX2020000182A MX2020000182A MX2020000182A MX 2020000182 A MX2020000182 A MX 2020000182A MX 2020000182 A MX2020000182 A MX 2020000182A MX 2020000182 A MX2020000182 A MX 2020000182A MX 2020000182 A MX2020000182 A MX 2020000182A
Authority
MX
Mexico
Prior art keywords
empty
probiotic
swine
subtilis
strain
Prior art date
Application number
MX2020000182A
Other languages
English (en)
Inventor
Stefan Pelzer
Guido Meurer
Jessica Kleinbölting
Stella Molck
Maike Kipker
Claudia Borgmeier
Sandra Herbold
Daniel Petri
Christos Giatsis
Lorena Stannek-Göbel
Kiran Doranalli
John Khun Kyaw Htoo
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of MX2020000182A publication Critical patent/MX2020000182A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/123—Addition of microorganisms or cultured milk products; Addition of enzymes; Addition of starter cultures other than destillates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/061—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)

Abstract

La invención actual se refiere a una nueva cepa de B. subtilis con fuerte inhibición de patógenos relacionados con porcinos y aves de corral y su uso como probió.
MX2020000182A 2017-06-30 2018-06-28 Cepa bacillus subtilis con actividad probiotica. MX2020000182A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17179052 2017-06-30
CN201710618158 2017-07-26
PCT/EP2018/067422 WO2019002471A1 (en) 2017-06-30 2018-06-28 DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY

Publications (1)

Publication Number Publication Date
MX2020000182A true MX2020000182A (es) 2020-07-22

Family

ID=62705610

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000182A MX2020000182A (es) 2017-06-30 2018-06-28 Cepa bacillus subtilis con actividad probiotica.

Country Status (8)

Country Link
US (1) US20200113952A1 (es)
EP (1) EP3645751A1 (es)
JP (1) JP7104078B2 (es)
CN (1) CN109207390A (es)
BR (1) BR112019027977A2 (es)
MX (1) MX2020000182A (es)
WO (1) WO2019002471A1 (es)
ZA (1) ZA202000428B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11173184B2 (en) 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
JP2022516797A (ja) * 2019-01-10 2022-03-02 エボニック オペレーションズ ゲーエムベーハー 発酵ブロスおよびその使用
CN109907072B (zh) * 2019-03-31 2021-02-26 浙江大学 载菌纳米壳聚糖畜舍消毒剂及其制备方法和应用
EP3794952A1 (en) * 2019-09-19 2021-03-24 DSM IP Assets B.V. Feed additive comprising bacillus strains for increasing vitamine e absorption
JPWO2021177464A1 (es) * 2020-03-06 2021-09-10
EP4228424A1 (en) * 2020-10-15 2023-08-23 DSM IP Assets B.V. Methods of modulating gastrointestinal metabolites
CN112401073A (zh) * 2020-11-05 2021-02-26 谷实生物集团股份有限公司 一种调节育肥猪生长性能的复合益生菌发酵饲料
CN113025534B (zh) * 2021-04-26 2022-05-27 佛山市南海东方澳龙制药有限公司 一株具有较强抑菌作用的新种芽孢杆菌x901株及其应用
CN113249255B (zh) * 2021-05-18 2022-08-05 山东康地恩生物科技有限公司 一种防控禽肠炎的枯草芽孢杆菌及其应用
CN113801825A (zh) * 2021-10-21 2021-12-17 厦门海嘉成生物科技有限公司 一种产生活性肽的枯草芽孢杆菌及其应用
CN113699085B (zh) * 2021-11-01 2022-02-08 渤海水产科技(滨州)有限公司 拮抗菌ed5及其应用
WO2023196003A1 (en) * 2022-04-07 2023-10-12 Bio-Cat Microbials, Llc Bacillus compositions and uses thereof
CN115197876B (zh) * 2022-06-02 2023-05-09 浙江海洋大学 一种枯草芽孢杆菌fnfh_bs08及其应用
CN115386515B (zh) * 2022-08-03 2023-11-17 华中农业大学 用于改善犊牦牛抗氧化能力和调节肠道菌群的枯草芽孢杆菌及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63209580A (ja) 1987-02-25 1988-08-31 Karupisu Shokuhin Kogyo Kk バチルス・ズブチリスｃ−３１０２
ATE195140T1 (de) 1996-12-20 2000-08-15 Novo Nordisk As Peniophora phytase
CN1255143A (zh) 1997-05-09 2000-05-31 阿格拉奎斯特公司 控制植物疾病和黄瓜十二星叶甲的芽孢杆菌新型菌株
BR0007655A (pt) 1999-01-22 2001-11-06 Novozymes As Fitase, sequência de dna, vetor, célula hospedeira microbiana, processo para produzir uma fitase, e, alimento, gênero alimentìcio ou composição farmacêutica
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP2295553A1 (en) 2002-02-08 2011-03-16 Novozymes A/S Phytase variants
US7247299B2 (en) 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US20080057047A1 (en) 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
KR100850743B1 (ko) * 2006-12-07 2008-08-06 (주)셀텍 바실러스 서브틸리스 및 이를 이용한 생균제
US8021654B2 (en) 2008-03-14 2011-09-20 Danisco A/S Methods of treating pigs with Bacillus strains
AU2009293213C1 (en) * 2008-09-17 2015-04-30 Bayer Cropscience Lp Method for using a Bacillus subtilis strain to enhance animal health
DK2547348T3 (da) * 2010-03-17 2015-08-24 Bayer Cropscience Lp Fremgangsmåde til anvendelse af en bacillus subtilis-stamme til profylakse og behandling af mave-tarm-tilstande
EP3486313A1 (en) * 2012-04-13 2019-05-22 Chr. Hansen A/S Antibiotic sensitive bacillus strains having antimicrobial effect against e. coli and clostridium perfringens and having high sporulation capacity
CN112806471B (zh) * 2012-08-03 2024-03-12 杜邦营养生物科学有限公司 饲料添加剂组合物
US10576519B2 (en) * 2015-09-10 2020-03-03 Locus Oil Ip Company, Llc Enhanced microbial production of biosurfactants and other products, and uses thereof
WO2017048636A1 (en) * 2015-09-14 2017-03-23 Agri-King, Inc. Bacteria and enzymes produced therefrom and methods of using same

Also Published As

Publication number Publication date
US20200113952A1 (en) 2020-04-16
CN109207390A (zh) 2019-01-15
JP2020525034A (ja) 2020-08-27
JP7104078B2 (ja) 2022-07-20
ZA202000428B (en) 2021-04-28
BR112019027977A2 (pt) 2020-07-07
WO2019002471A1 (en) 2019-01-03
EP3645751A1 (en) 2020-05-06

Similar Documents

Publication Publication Date Title
MX2020000182A (es) Cepa bacillus subtilis con actividad probiotica.
MX2018014476A (es) Cepa de bacillus subtilis con actividad probiotica.
SG10201805246XA (en) Approximated parameter adaptation
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
MX2017016564A (es) Composiciones que comprenden cepas bacterianas.
MX2020003425A (es) Tratamiento de trastornos inflamatorios.
MX2020003760A (es) Formulaciones de niraparib.
MX2017004473A (es) Formulaciones de betalactamasa y usos de las mismas.
MX2020004071A (es) Derivados de aztreonam y usos de los mismos.
MX2018014497A (es) Cepa de bacillus licheniformis con actividad probiotica.
MX2017014459A (es) Compuestos de tioeter como inhibidores de la nitrificacion.
MX2020004227A (es) Estructura plana termicamente fijable.
MX2020004424A (es) Formulacion aerosolizable.
MX2020004241A (es) Conector y montaje de conector.
AU201714352S (en) Ratchet Handle
AU201714353S (en) Ratchet Handle
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
AU201810263S (en) Soap Bar
MX2020004662A (es) Ajuste planificado del contorno mediante especificaciones correspondientes.
MX2017013278A (es) Odorante osmanthus.
MX2020003640A (es) Lamina de acero electrico de grano orientado.
GB201802720D0 (en) Pathogenic bacteria
MX2020004245A (es) Estabilizador mejorado para poliamidas.
MX2020004272A (es) Cartucho configurado para formar una parte de una pezonera y una pezonera.
MX2020003511A (es) Formulaciones orales de bendamustina.